{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:33:08Z","timestamp":1774344788008,"version":"3.50.1"},"reference-count":22,"publisher":"National Athletic Trainers' Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:sec>\n          <jats:title>Objective:<\/jats:title>\n          <jats:p>To emphasize the potentially harmful effects of high-intensity exercise on cardiac health and the fine line between physiologic and pathologic adaptation to chronic exercise in the elite athlete. This case also highlights the crucial need for regular evaluation of symptoms that suggest cardiac abnormality in athletes.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Background:<\/jats:title>\n          <jats:p>Sudden cardiac death (SCD) of young athletes is always a tragedy because they epitomize health. However, chronic, high-intensity exercise sometimes has harmful effects on cardiac health, and pathologic changes, such as myocardial fibrosis, have been observed in endurance athletes. In this case, a highly trained 30-year-old cyclist reported brief palpitations followed by presyncope feeling while exercising. Immediate investigations revealed nonsustained ventricular tachycardia originating from the left ventricle on a stress test associated with myocardial fibrosis of the left ventricle as shown with magnetic resonance imaging. Despite complete cessation of exercise, life-threatening arrhythmia and fibrosis persisted, leading to complete restriction from competition.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Differential Diagnosis:<\/jats:title>\n          <jats:p>Hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, myocarditis, postmyocarditis, use of drugs and toxic agents, doping, and systemic disease.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Treatment:<\/jats:title>\n          <jats:p>The arrhythmia could not be treated with catheter ablation procedure or drug suppression. Therefore, the athlete was instructed to withdraw completely from sport participation and to have a medical follow-up twice each year.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Uniqueness:<\/jats:title>\n          <jats:p>To our knowledge, no other report of left ventricle exercise-induced fibrosis associated with life-threatening arrhythmia in a living young elite athlete exists. Only postmortem evidence supports such myocardial pathologic adaptation to exercise.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Conclusions:<\/jats:title>\n          <jats:p>To prevent SCD in young athletes, careful attention must be paid to exercise-related symptoms that suggest a cardiac abnormality because they more often are linked to life-threatening cardiovascular disease.<\/jats:p>\n        <\/jats:sec>","DOI":"10.4085\/1062-6050-47.2.224","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T15:04:04Z","timestamp":1488467044000},"page":"224-227","source":"Crossref","is-referenced-by-count":3,"title":["Left Ventricle Fibrosis Associated With Nonsustained Ventricular Tachycardia in an Elite Athlete: Is Exercise Responsible? A Case Report"],"prefix":"10.4085","volume":"47","author":[{"given":"Mathias","family":"Poussel","sequence":"first","affiliation":[{"name":"Department of Pulmonary Function Testing and Exercise Test,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Djaballah","sequence":"additional","affiliation":[{"name":"Department of Cardiology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Laroppe","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Function Testing and Exercise Test,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Brembilla-Perrot","sequence":"additional","affiliation":[{"name":"Department of Cardiology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Marie","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, CHU of Nancy, Vandoeuvre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Chenuel","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Function Testing and Exercise Test,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2557","reference":[{"issue":"12","key":"i1062-6050-47-2-224-b1","series-title":"Circulation","first-page":"1643","article-title":"Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update. A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.","volume":"115","year":"2007","unstructured":"Maron, BJ, PDThompson, and MJAckerman. et al.Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update. A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.Circulation2007. 11512:1643\u20131655."},{"issue":"5","key":"i1062-6050-47-2-224-b2","series-title":"Eur Heart J.","first-page":"516","article-title":"Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.","volume":"26","year":"2005","unstructured":"Corrado, D, APelliccia, and HHBj\u00f8rnstad. et al.Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.Eur Heart J.2005. 265:516\u2013524."},{"issue":"2","key":"i1062-6050-47-2-224-b3","series-title":"Sports Med.","first-page":"73","article-title":"Endurance exercise and injury to the heart.","volume":"16","year":"1993","unstructured":"Rowe, WJ.\n          \n          Endurance exercise and injury to the heart.\n          Sports Med.\n          1993. 162:73\u201379."},{"issue":"suppl 3","key":"i1062-6050-47-2-224-b4","series-title":"Heart Lung Circ","first-page":"S102","article-title":"Exercise: is it possible to have too much of a good thing?","volume":"16","year":"2007","unstructured":"La Gerche, A and DL.Prior. Exercise: is it possible to have too much of a good thing?Heart Lung Circ2007. 16suppl 3:S102\u2013104."},{"issue":"7","key":"i1062-6050-47-2-224-b5","series-title":"Heart.","first-page":"860","article-title":"Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise.","volume":"94","year":"2008","unstructured":"La Gerche, A, KAConnelly, DJMooney, AIMacIsaac, and DL.Prior. Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise.Heart.2008. 947:860\u2013866."},{"issue":"25","key":"i1062-6050-47-2-224-b6","series-title":"Circulation.","first-page":"3069","article-title":"Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis.","volume":"104","year":"2001","unstructured":"Kawara, T, RDerksen, and JRde Groot. et al.Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis.Circulation.2001. 10425:3069\u20133075."},{"issue":"2","key":"i1062-6050-47-2-224-b7","series-title":"Eur Heart J.","first-page":"243","article-title":"Recommendations for interpretation of 12-lead electrocardiogram in the athlete: Section of Sports Cardiology, European Association of Cardiovascular Prevention and Rehabilitation.","volume":"31","year":"2010","unstructured":"Corrado, D, APelliccia, and HHeidbuchel. et al.Recommendations for interpretation of 12-lead electrocardiogram in the athlete: Section of Sports Cardiology, European Association of Cardiovascular Prevention and Rehabilitation.Eur Heart J.2010. 312:243\u2013259."},{"issue":"3","key":"i1062-6050-47-2-224-b8","series-title":"Eur J Echocardiogr.","first-page":"350","article-title":"Left ventricular hypertrophy in athletes.","volume":"10","year":"2009","unstructured":"Rawlins, J, ABahn, and S.Sharma. Left ventricular hypertrophy in athletes.Eur J Echocardiogr.2009. 103:350\u2013356."},{"issue":"17","key":"i1062-6050-47-2-224-b9","series-title":"Eur Heart J.","first-page":"2099","article-title":"ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).","volume":"27","year":"2006","unstructured":"Zipes, DP, AJCamm, and MBorggrefe. et al.ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).Eur Heart J.2006. 2717:2099\u20132140."},{"issue":"8","key":"i1062-6050-47-2-224-b10","series-title":"J Am Coll Cardiol.","first-page":"1313","article-title":"Bethesda conference report: 36th Bethesda Conference. Eligibility recommendations for competitive athletes with cardiovascular abnormalities.","volume":"45","year":"2005","unstructured":"Maron, BJ, DPZipes, and MJAckerman. et al.Bethesda conference report: 36th Bethesda Conference. Eligibility recommendations for competitive athletes with cardiovascular abnormalities.J Am Coll Cardiol.2005. 458:1313\u20131375."},{"issue":"5","key":"i1062-6050-47-2-224-b11","series-title":"Eur J Cardiovasc Prev Rehabil.","first-page":"676","article-title":"Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions, part II: ventricular arrhythmias, channelopathies and implantable defibrillators.","volume":"13","year":"2006","unstructured":"Heidb\u00fcchel, H, DCorrado, and ABiffi. et al.Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions, part II: ventricular arrhythmias, channelopathies and implantable defibrillators.Eur J Cardiovasc Prev Rehabil.2006. 135:676\u2013686."},{"issue":"24","key":"i1062-6050-47-2-224-b12","series-title":"Circulation.","first-page":"3109","article-title":"Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).","volume":"107","year":"2003","unstructured":"Thompson, PD, DBuchner, and ILPina. et al.Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).Circulation.2003. 10724:3109\u20133116."},{"issue":"13","key":"i1062-6050-47-2-224-b13","series-title":"N Engl J Med.","first-page":"1370","article-title":"Cardiac plasticity.","volume":"358","year":"2008","unstructured":"Hill, JA and EN.Olson. Cardiac plasticity.N Engl J Med.2008. 35813:1370\u20131380."},{"issue":"6","key":"i1062-6050-47-2-224-b14","series-title":"Fiziol Zh SSSR Im I M Sechenova.","first-page":"56","article-title":"Physiological and chemical adaptation to muscular activity in relation to length of rest periods between exertions during training.","volume":"47","year":"1961","unstructured":"Yakovlev, NN, SVKaledin, and AFKrasnova. et al.Physiological and chemical adaptation to muscular activity in relation to length of rest periods between exertions during training.Fiziol Zh SSSR Im I M Sechenova.1961. 476:56\u201359."},{"issue":"8","key":"i1062-6050-47-2-224-b15","series-title":"Med Sci Sports Exerc.","first-page":"1416","article-title":"Clinical significance of cardiac damage and changes in function after exercise.","volume":"40","year":"2008","unstructured":"Whyte, GP.\n          \n          Clinical significance of cardiac damage and changes in function after exercise.\n          Med Sci Sports Exerc.\n          2008. 408:1416\u20131423."},{"issue":"7","key":"i1062-6050-47-2-224-b16","series-title":"Br J Sports Med.","first-page":"447","article-title":"Biochemical evidence of myocardial fibrosis in veteran endurance athletes.","volume":"41","year":"2007","unstructured":"Lindsay, MM and FG.Dunn. Biochemical evidence of myocardial fibrosis in veteran endurance athletes.Br J Sports Med.2007. 417:447\u2013452."},{"issue":"4","key":"i1062-6050-47-2-224-b17","series-title":"Br J Sports Med","first-page":"304","article-title":"Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause?","volume":"42","year":"2008","unstructured":"Whyte, GP, MSheppard, and KGeorge. et al.Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause?Br J Sports Med2008. 424:304\u2013305."},{"issue":"5","key":"i1062-6050-47-2-224-b18","series-title":"Heart.","first-page":"588","article-title":"Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment.","volume":"83","year":"2000","unstructured":"Corrado, D, CBasso, and G.Thiene. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment.Heart.2000. 835:588\u2013595."},{"issue":"11","key":"i1062-6050-47-2-224-b19","series-title":"Circulation.","first-page":"e101","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy: need for an international registry.","volume":"101","year":"2000","unstructured":"Corrado, D, GFontaine, and FIMarcus. et al. for the Study Group on Arrhythmogenic Right Ventricular Dysplasia\/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the World Heart FederationArrhythmogenic right ventricular dysplasia\/cardiomyopathy: need for an international registry.Circulation.2000. 10111:e101\u2013e106."},{"issue":"6","key":"i1062-6050-47-2-224-b20","series-title":"Clin J Sport Med","first-page":"417","article-title":"Evaluating cardiac symptoms in the athlete: is it safe to play?","volume":"15","year":"2005","unstructured":"Rowland, TW.\n          \n          Evaluating cardiac symptoms in the athlete: is it safe to play?\n          Clin J Sport Med\n          2005. 156:417\u2013420."},{"issue":"5","key":"i1062-6050-47-2-224-b21","series-title":"Clin J Sport Med.","first-page":"429","article-title":"Practical management: a systematic approach to the evaluation of exercise-related syncope in athletes.","volume":"19","year":"2009","unstructured":"O'Connor, FG, BDLevine, MAChildress, CAAspludh, and RG.Oriscello. Practical management: a systematic approach to the evaluation of exercise-related syncope in athletes.Clin J Sport Med.2009. 195:429\u2013434."},{"issue":"23","key":"i1062-6050-47-2-224-b22","series-title":"JAMA.","first-page":"3011","article-title":"Medical and legal issues in the cardiovascular evaluation of competitive athletes.","volume":"294","year":"2005","unstructured":"Paterick, TE, TJPaterick, GFFletcher, and BJ.Maron. Medical and legal issues in the cardiovascular evaluation of competitive athletes.JAMA.2005. 29423:3011\u20133018."}],"container-title":["Journal of Athletic Training"],"original-title":[],"link":[{"URL":"https:\/\/nata.kglmeridian.com\/view\/journals\/attr\/47\/2\/article-p224.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jat\/article-pdf\/47\/2\/224\/1455153\/1062-6050-47_2_224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/nata.kglmeridian.com\/downloadpdf\/journals\/attr\/47\/2\/article-p224.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/nata.kglmeridian.com\/downloadpdf\/journals\/attr\/47\/2\/article-p224.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:48:04Z","timestamp":1749689284000},"score":1,"resource":{"primary":{"URL":"https:\/\/nata.kglmeridian.com\/view\/journals\/attr\/47\/2\/article-p224.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":22,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.4085\/1062-6050-47.2.224","relation":{},"ISSN":["1062-6050"],"issn-type":[{"value":"1062-6050","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}